Cargando…

The malignancy of chordomas is enhanced via a circTLK1/miR-16-5p/Smad3 positive feedback axis

CircRNAs play crucial roles in various malignancies via an increasing number of reported regulatory mechanisms, including the classic sponging mechanism between circRNAs and micro RNAs (miRNAs). We performed bioinformatic analyses and identified circTLK1 as a regulator of malignant chordoma progress...

Descripción completa

Detalles Bibliográficos
Autores principales: Lou, Jingbing, Zhang, Hongliang, Huang, Qingshan, Chen, Chenglong, Wang, Wei, Niu, Jianfang, Xu, Jiuhui, Ren, Tingting, Huang, Yi, Tang, Xiaodong, Guo, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932141/
https://www.ncbi.nlm.nih.gov/pubmed/36792585
http://dx.doi.org/10.1038/s41420-023-01332-1
_version_ 1784889385708158976
author Lou, Jingbing
Zhang, Hongliang
Huang, Qingshan
Chen, Chenglong
Wang, Wei
Niu, Jianfang
Xu, Jiuhui
Ren, Tingting
Huang, Yi
Tang, Xiaodong
Guo, Wei
author_facet Lou, Jingbing
Zhang, Hongliang
Huang, Qingshan
Chen, Chenglong
Wang, Wei
Niu, Jianfang
Xu, Jiuhui
Ren, Tingting
Huang, Yi
Tang, Xiaodong
Guo, Wei
author_sort Lou, Jingbing
collection PubMed
description CircRNAs play crucial roles in various malignancies via an increasing number of reported regulatory mechanisms, including the classic sponging mechanism between circRNAs and micro RNAs (miRNAs). We performed bioinformatic analyses and identified circTLK1 as a regulator of malignant chordoma progression. Moreover, we observed that circTLK1 showed high expression in chordoma cells and tissues, while circTLK1 interference suppressed chordoma cell proliferation and invasion. In addition, circTLK1 directly interacted with miR-16-5p, which has previously been shown to repress chordoma, and circTLK1 knockdown suppressed Smad3 expression. Chromatin immunoprecipitation sequencing further demonstrated that Smad3 acts as a positive regulator by interacting with TLK1, thereby mediating the circTLK1/miR-16-5p/Smad3 positive feedback axis. Taken together, our findings suggested that the disruption of the circTLK1/miR-16-5p/Smad3 positive feedback pathway, particularly via the Smad3 inhibitor SIS3, could be a promising therapeutic strategy.
format Online
Article
Text
id pubmed-9932141
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-99321412023-02-17 The malignancy of chordomas is enhanced via a circTLK1/miR-16-5p/Smad3 positive feedback axis Lou, Jingbing Zhang, Hongliang Huang, Qingshan Chen, Chenglong Wang, Wei Niu, Jianfang Xu, Jiuhui Ren, Tingting Huang, Yi Tang, Xiaodong Guo, Wei Cell Death Discov Article CircRNAs play crucial roles in various malignancies via an increasing number of reported regulatory mechanisms, including the classic sponging mechanism between circRNAs and micro RNAs (miRNAs). We performed bioinformatic analyses and identified circTLK1 as a regulator of malignant chordoma progression. Moreover, we observed that circTLK1 showed high expression in chordoma cells and tissues, while circTLK1 interference suppressed chordoma cell proliferation and invasion. In addition, circTLK1 directly interacted with miR-16-5p, which has previously been shown to repress chordoma, and circTLK1 knockdown suppressed Smad3 expression. Chromatin immunoprecipitation sequencing further demonstrated that Smad3 acts as a positive regulator by interacting with TLK1, thereby mediating the circTLK1/miR-16-5p/Smad3 positive feedback axis. Taken together, our findings suggested that the disruption of the circTLK1/miR-16-5p/Smad3 positive feedback pathway, particularly via the Smad3 inhibitor SIS3, could be a promising therapeutic strategy. Nature Publishing Group UK 2023-02-15 /pmc/articles/PMC9932141/ /pubmed/36792585 http://dx.doi.org/10.1038/s41420-023-01332-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Lou, Jingbing
Zhang, Hongliang
Huang, Qingshan
Chen, Chenglong
Wang, Wei
Niu, Jianfang
Xu, Jiuhui
Ren, Tingting
Huang, Yi
Tang, Xiaodong
Guo, Wei
The malignancy of chordomas is enhanced via a circTLK1/miR-16-5p/Smad3 positive feedback axis
title The malignancy of chordomas is enhanced via a circTLK1/miR-16-5p/Smad3 positive feedback axis
title_full The malignancy of chordomas is enhanced via a circTLK1/miR-16-5p/Smad3 positive feedback axis
title_fullStr The malignancy of chordomas is enhanced via a circTLK1/miR-16-5p/Smad3 positive feedback axis
title_full_unstemmed The malignancy of chordomas is enhanced via a circTLK1/miR-16-5p/Smad3 positive feedback axis
title_short The malignancy of chordomas is enhanced via a circTLK1/miR-16-5p/Smad3 positive feedback axis
title_sort malignancy of chordomas is enhanced via a circtlk1/mir-16-5p/smad3 positive feedback axis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932141/
https://www.ncbi.nlm.nih.gov/pubmed/36792585
http://dx.doi.org/10.1038/s41420-023-01332-1
work_keys_str_mv AT loujingbing themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT zhanghongliang themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT huangqingshan themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT chenchenglong themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT wangwei themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT niujianfang themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT xujiuhui themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT rentingting themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT huangyi themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT tangxiaodong themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT guowei themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT loujingbing malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT zhanghongliang malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT huangqingshan malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT chenchenglong malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT wangwei malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT niujianfang malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT xujiuhui malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT rentingting malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT huangyi malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT tangxiaodong malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis
AT guowei malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis